Kalium Lakes EBITDA margin
Was ist das EBITDA margin von Kalium Lakes?
EBITDA margin von Kalium Lakes Limited ist -412.10%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Materials Sektor auf ASX im Vergleich zu Kalium Lakes
Was macht Kalium Lakes?
Kalium Lakes Limited operates as an exploration and development company in Australia. It focuses on the development of 100% owned the Beyondie sulphate of potash project, which include 16 granted exploration licenses, two mining leases, and various miscellaneous licenses covering an area of approximately 1,800 square kilometers located in Western Australia. The company was founded in 2014 and is based in Balcatta, Australia.
Unternehmen mit ebitda margin ähnlich Kalium Lakes
- Vir Biotechnology Inc hat EBITDA margin von -415.62%
- Ondas hat EBITDA margin von -414.74%
- Axios Mobile Assets hat EBITDA margin von -414.57%
- Nuheara hat EBITDA margin von -413.72%
- Alterity Therapeutics hat EBITDA margin von -412.91%
- Alterity Therapeutics hat EBITDA margin von -412.91%
- Kalium Lakes hat EBITDA margin von -412.10%
- Co-Diagnostics Inc hat EBITDA margin von -411.73%
- Atara Biotherapeutics hat EBITDA margin von -411.00%
- Opgen Inc hat EBITDA margin von -410.85%
- Titan Medical hat EBITDA margin von -408.50%
- Stroud Resources hat EBITDA margin von -406.72%
- Last Mile hat EBITDA margin von -406.59%